Search Result "COX-1 and COX-2"
Clinical Implications of COX-1 and / or COX-2 Inhibition for the Distal Gastrointestinal Tract
Journal: Current Pharmaceutical Design
Volume: 9 Issue: 2 Year: 2003 Page: 2253-2266
Author(s): Angel Lanas, Julian Panes, Josep M. Pique
Evaluation of the Effect of α-L-Guluronic Acid (G2013) on COX-1, COX-2 Activity and Gene Expression for Introducing this Drug as a Novel NSAID with Immunomodulatory Property
Journal: Recent Patents on Inflammation & Allergy Drug Discovery
Volume: 12 Issue: 2 Year: 2018 Page: 162-168
Author(s): Abbas Mirshafiey,Seyed S. Mortazavi-Jahromi,Mahsa Taeb,Salvatore Cuzzocrea,Emanuela Esposito
The Molecular Basis of COX-2 Versus COX-1 Selectivity of Lumiracoxib by Molecular Docking Studies
Journal: Letters in Drug Design & Discovery
Volume: 4 Issue: 6 Year: 2007 Page: 422-425
Author(s): Celia M. Correa, Andre F. de Paula, Gilberto M.S. da Silva, Carlos M.R. SantAnna, Carlos A. M. Fraga, Eliezer J. Barreiro
Ester Prodrugs of Ketoprofen: Synthesis, In Vitro Stability, In Vivo Biological Evaluation and In Silico Comparative Docking Studies Against COX-1 and COX-2
Journal: Current Drug Discovery Technologies
Volume: 13 Issue: 1 Year: 2016 Page: 41-57
Author(s): Musa Ahmed,Faizul Azam,Abdul Gbaj,Abdulmottaleb E. Zetrini,Amna S. Abodlal,Abir Rghigh,Eman Elmahdi,Amel Hamza,Mabruk Salama,Salah M. Bensaber
Design, Synthesis and Biological Evaluation of New 1,3-diphenyl-3- (phenylamino)propan-1-ones as Selective Cyclooxygenase (COX-2) Inhibitors
Journal: Medicinal Chemistry
Volume: 14 Issue: 7 Year: 2018 Page: 652-659
Author(s): Shabnam Farzaneh,Soraya Shahhosseini,Hadi Arefi,Bahram Daraei,Marjan Esfahanizadeh,Afshin Zarghi
COX-2: Friend or Foe?
Journal: Current Pharmaceutical Design
Volume: 13 Issue: 1 Year: 2007 Page: 1715-1721
Author(s): Annalisa Iezzi, Claudio Ferri, Andrea Mezzetti, Francesco Cipollone
Cancer and Cyclooxygenase-2 (COX-2) Inhibition
Journal: Current Pharmaceutical Design
Volume: 10 Issue: 6 Year: 2004 Page: 627-634
Author(s): J. F. Evans, S. L.. Kargman
Update on SAR Studies Toward New COX-1 Selective Inhibitors
Journal: Current Medicinal Chemistry
Volume: 22 Issue: 37 Year: 2015 Page: 4271-4292
Author(s): Paola Vitale,Antonio Scilimati,Maria Grazia Perrone
Chebulagic Acid Synergizes the Cytotoxicity of Doxorubicin in Human Hepatocellular Carcinoma Through COX-2 Dependant Modulation of MDR-1
Journal: Medicinal Chemistry
Volume: 7 Issue: 5 Year: 2011 Page: 432-442
Author(s): Chandrani Achari, Gorla V. Reddy, T. C.M. Reddy, Pallu Reddanna
Current Status of COX-2 Inhibitors
Journal: Mini-Reviews in Medicinal Chemistry
Volume: 8 Issue: 1 Year: 2008 Page: 73-90
Author(s): Palwinder Singh, Anu Mittal